Deep Brain Stimulation in Patients With LUTS

Status Completed

Clinical Trial Summary

Deep brain stimulation (DBS) is a neurosurgical procedure using a device that improves motor symptoms of specific neurological and movement disorders such as Parkinson's disease or Essential Tremor. As part of the patient's care, the DBS is implanted when symptoms cannot be satisfactorily controlled with medications or conventional therapies. Lower urinary tract symptoms are common in patients who have underlying neurological or movement disorders and control over lower urinary tract function is poorly understood. In this study investigators are evaluating the effects of DBS on lower urinary tract function.

Clinical Trial Description

Deep brain stimulation (DBS) is a neurosurgical procedure that improves motor symptoms of specific neurological and movement disorders such as Parkinson's disease or Essential Tremor. DBS is implanted when symptoms cannot be satisfactorily controlled with medications or conventional therapies. After insertion of deep electrodes, electrical stimulation will be delivered to modulate specific neurons in certain areas of the brain. Despite, the known motor effects for DBS, its nonmotor effects on other organs such as the urinary tract and bladder function remains unclear. Lower urinary tract symptoms such as frequency, urgency, urinary incontinence, or incomplete bladder emptying are common in patients who have underlying neurological or movement disorders. In addition, central neural control over lower urinary tract function is still poorly understand. In this trial investigators plan to evaluate the effects of Deep Brain Stimulators (DBS) on lower urinary tract function. This trial is designed to test the hypothesis that DBS improves objective and subjective symptoms of lower urinary tract function in specific patient populations. The investigators plan to test this hypothesis by using validated patient reported outcome questionnaires and urodynamic testing (both are part of routine care for neurogenic bladder) before and after DBS implantation. In addition, this trial will shed some light in understanding higher neural control of bladder and potentially identify target areas for future intervention. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03202251
Study type	Observational
Source	The Methodist Hospital Research Institute
Contact
Status	Completed
Phase
Start date	April 11, 2017
Completion date	March 25, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02978638` - Electrical Stimulation for Continence After Spinal Cord Injury	N/A
Enrolling by invitation	`NCT06429631` - The Effect of CIC Education on QOL and Compliance With Mobile Application in Individuals With Spinal Cord Injury.	N/A
Completed	`NCT03573726` - Use of a Diurnal Indwelling Urethral Catheter to Improve Quality of Life	N/A
Recruiting	`NCT06059066` - Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction	N/A
Completed	`NCT01429090` - Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide Solution	Phase 1
Recruiting	`NCT05587101` - Neurogenic Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis
Terminated	`NCT03843073` - Connected Catheter- Safety and Effectiveness Study	N/A
Terminated	`NCT04059159` - Connected Catheter - Safety and Effectiveness Study	N/A
Completed	`NCT05861024` - Urinary Calculi After Bladder Augmentation in Children
Completed	`NCT05858840` - Urinary Artificial Sphincter in Children
Completed	`NCT04074616` - Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation	N/A
Completed	`NCT05683938` - GentleCath™ Air Intermittent Catheter Smartwatch Real Life Pilot Study
Completed	`NCT04543552` - A Comparative Analysis of Portable Bladder Scanner to Determine Age/ Volume Specific Accuracy in 0-6 Years of Children
Active, not recruiting	`NCT06247033` - Efficacies of Different Managements in Patients With Overactive Bladder With Stroke	N/A
Withdrawn	`NCT01305681` - Bacterial Properties With LoFric® Catheters During Clean Intermittent Catheterization	Phase 1/Phase 2
Recruiting	`NCT04248322` - Qualitative Assessment of the Impact of TTNS on QOL and Participation
Recruiting	`NCT05301335` - Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study	N/A
Recruiting	`NCT04924569` - Continence Care Registry
Completed	`NCT01716624` - Botox Versus Oxybutynin as First Line Treatment for the Poorly Compliant Pediatric Neurogenic Bladder	Phase 3
Completed	`NCT01297647` - Incidence of Urinary Tract Infection After Urodynamic Investigation	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.